RT @EnzoLifeSci: Check out how these scientists are using our Efluxx-ID® Green assay in their research on the enhancement of the bortezomi…
Check out how these scientists are using our Efluxx-ID® Green assay in their research on the enhancement of the bortezomib treatment via targeted radiotherapy of resistant cancer stem cells. https://t.co/ccyCtqZLAj #drugdiscovery #research #scientist #BT
RT @cancerscnews: 🥼From researchers at Sungkyunkwan University (@skkuintl), tumor response to bortezomib treatment was enhanced by targeted…
🥼From researchers at Sungkyunkwan University (@skkuintl), tumor response to bortezomib treatment was enhanced by targeted radiotherapy of resistant #CancerStemCells that had poor proteasome function. Full article in @SciReports: https://t.co/CF1b9Y3ZQS ht
🆕 in @SciReports! Researchers from Sungkyunkwan University (@SKKU_1398) show that targeting poor proteasomal function with radioiodine eliminates CT26 colon #CancerStemCells resistant to bortezomib therapy🏥 . https://t.co/gni6qEgAdG https://t.co/CLEbfPNK